H Lundbeck A/S Class A (HLUBF) Stock Price & News

H. Lundbeck A/S, commonly referred to as Lundbeck, is a Danish international pharmaceutical company engaged in the research, development, manufacturing, marketing and sale of pharmaceuticals across the world. The company’s products are targeted at brain diseases, including depression, schizophrenia, Alzheimer's disease, Parkinson's disease and migraine. Wikipedia

About H Lundbeck A/S Class A

CEOCharl Van Zyl

Employees5K

FoundedAug 14, 1915

Headquarters-

SectorPharmaceutical industry

Websitelundbeck.com

All values in DKK	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	6.28B	6.09B	7.12B	6.46B
Cost of goods sold	846.00M	1.24B	1.30B	1.27B
Cost of revenue	846.00M	1.24B	1.30B	1.27B
Research and development expenses	1.16B	820.00M	1.38B	1.43B
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	2.15B	2.54B	2.13B	2.28B
Operating expense	3.31B	4.36B	3.52B	3.70B
Total operating expenses	4.16B	5.60B	4.82B	4.96B
Operating income	2.12B	490.00M	2.31B	1.50B
Other non operating income	-	-32.00M	-	-
EBT including unusual items	1.41B	360.00M	2.13B	1.47B
EBT excluding unusual items	1.90B	567.00M	2.28B	1.47B
Income tax expense	311.00M	387.00M	468.00M	323.00M
Effective tax rate	22.03%	107.50%	22.01%	21.96%
Other operating expenses	-	997.00M	-	-11.00M
Net income	1.10B	-27.00M	1.66B	1.15B
Net profit margin	17.53%	-0.44%	23.27%	17.76%
Earnings per share	1.44	0.94	2.16	1.54
Interest and investment income	-	199.00M	-	-
Interest expense	-219.00M	-83.00M	-29.00M	-27.00M
Net interest expenses	-219.00M	116.00M	-29.00M	-27.00M
Depreciation and amortization charges	-	-	-	-
EBITDA	2.55B	956.00M	2.78B	1.98B
Gain or loss from assets sale	-	-	-	-

Finance

Ask anything